Net Cash Provided by (Used in) Financing Activities in USD of PharmaCyte Biotech, Inc. from Q2 2010 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
PharmaCyte Biotech, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and change rate from Q2 2010 to Q2 2025.
  • PharmaCyte Biotech, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending July 31, 2025 was $0.000.
  • PharmaCyte Biotech, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2024 was -$25M, a 134% decline from 2023.
  • PharmaCyte Biotech, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was -$10.7M, a 21% increase from 2022.
  • PharmaCyte Biotech, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was -$13.6M, a 116% decline from 2021.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)

PharmaCyte Biotech, Inc. Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2025 $0 +$10.2M May 1, 2025 Jul 31, 2025 10-Q 2025-09-15
Q2 2024 -$10.2M -$16.5M -262% May 1, 2024 Jul 31, 2024 10-Q 2025-09-15
Q2 2023 $6.28M +$8.37M May 1, 2023 Jul 31, 2023 10-Q 2024-09-17
Q2 2022 -$2.09M -$2.09M May 1, 2022 Jul 31, 2022 10-Q 2023-09-18
Q2 2021 $0 -$1.82M -100% May 1, 2021 Jul 31, 2021 10-Q 2022-09-14
Q2 2020 $1.82M +$1.24M +212% May 1, 2020 Jul 31, 2020 10-Q 2021-09-14
Q2 2019 $583K -$813K -58.2% May 1, 2019 Jul 31, 2019 10-Q 2020-09-11
Q2 2018 $1.4M -$356K -20.4% May 1, 2018 Jul 31, 2018 10-Q 2019-09-13
Q2 2017 $1.75M +$426K +32.1% May 1, 2017 Jul 31, 2017 10-Q 2018-09-12
Q2 2016 $1.33M May 1, 2016 Jul 31, 2016 10-Q 2017-09-13
Q2 2013 $1.74M +$1.45M +499% May 1, 2013 Jul 31, 2013 10-Q 2013-09-16
Q2 2012 $290K -$176K -37.8% May 1, 2012 Jul 31, 2012 10-Q 2013-09-16
Q2 2011 $466K +$453K +3481% May 1, 2011 Jul 31, 2011 10-Q 2012-09-19
Q2 2010 $13K May 1, 2010 Jul 31, 2010 10-Q/A 2011-09-20

PharmaCyte Biotech, Inc. Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$25M -$14.3M -134% May 1, 2024 Apr 30, 2025 10-K 2025-08-11
2023 -$10.7M +$2.85M +21% May 1, 2023 Apr 30, 2024 10-K 2025-08-11
2022 -$13.6M -$101M -116% May 1, 2022 Apr 30, 2023 10-K 2024-08-13
2021 $87.3M +$82.7M +1783% May 1, 2021 Apr 30, 2022 10-K 2023-07-31
2020 $4.64M +$1.91M +70.1% May 1, 2020 Apr 30, 2021 10-K 2022-07-28
2019 $2.73M +$383K +16.4% May 1, 2019 Apr 30, 2020 10-K 2021-08-10
2018 $2.34M -$339K -12.6% May 1, 2018 Apr 30, 2019 10-K 2020-08-13
2017 $2.68M -$2.2M -45.1% May 1, 2017 Apr 30, 2018 10-K 2019-08-13
2016 $4.88M May 1, 2016 Apr 30, 2017 10-K 2018-07-20
2012 $1.22M +$131K +12% May 1, 2012 Apr 30, 2013 10-K 2013-07-29
2011 $1.09M +$808K +287% May 1, 2011 Apr 30, 2012 10-K 2013-07-29
2010 $282K May 1, 2010 Apr 30, 2011 10-K 2012-08-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.